OLBA HEALTHCARE HOLDINGS, Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥80 | 0.0% |
| 2025 | ¥80 | 0.0% |
| 2024 | ¥80 | +14.3% |
| 2023 | ¥70 | +16.7% |
| 2022 | ¥60 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Income Statement | |||
| Revenue | ¥107,959M | ¥110,473M | ¥118,565M |
| Gross Profit | ¥12,504M | ¥12,955M | ¥13,601M |
| Operating Income | ¥2,073M | ¥2,151M | ¥2,227M |
| Pretax Income | ¥2,157M | ¥2,174M | ¥2,263M |
| Net Income | ¥1,535M | ¥1,414M | ¥1,500M |
| EPS | ¥252.80 | ¥234.90 | ¥251.68 |
| Operating Margin | 1.92% | 1.95% | 1.88% |
| Balance Sheet | |||
| Total Assets | ¥39,969M | ¥40,878M | ¥43,237M |
| Total Equity | ¥9,093M | ¥10,328M | ¥11,374M |
| Total Liabilities | ¥30,875M | ¥30,551M | ¥31,864M |
| Cash | ¥3,190M | ¥2,400M | ¥2,731M |
| Interest-bearing Debt | ¥1,284M | ¥1,921M | ¥1,630M |
| Equity Ratio | 22.75% | 25.26% | 26.31% |
| D/E Ratio | 0.14 | 0.19 | 0.14 |
| Cash Flow | |||
| Operating CF | ¥2,421M | -¥660M | ¥2,084M |
| Investing CF | -¥212M | -¥306M | -¥673M |
| Financing CF | -¥1,170M | ¥176M | -¥1,090M |
| Free CF | ¥1,967M | -¥911M | ¥1,607M |
| Efficiency | |||
| ROE | 16.88% | 13.69% | 13.19% |
| ROA | 3.84% | 3.46% | 3.47% |
Latest IR Information
-
Orba HealthCare Holdings, Inc. 2026 June Term Financial Summary
For the six months ended June 2026, consolidated net sales were 12,659,500,000 yen, operating income was 1,679,828 thousand yen, and net income attributable to owners of the parent was 1,112,433 thousand yen. Year-over-year, net sales increased by 3.2%, operating income...
Read more -
Notice Regarding the Revision of the Stock Compensation Program for Directors
Read more -
Notice Regarding the Revision of the Stock Compensation Program for Directors
Read more
Latest News (5 items)
Company Information
About
OLBA HEALTHCARE HOLDINGS, Inc., together with its subsidiaries, operates as a distributor of medical equipment and pharmaceuticals in Japan. The company operates through three segments: Medical Equipment Business, Specialty Product Delivery (SPD) Business, and Nursing Care Products Business. The Medical Equipment Business segment engages in the wholesale of medical equipment comprising artificial joints, coronary stents, steel instruments, osteosynthesis materials made of metal and ceramics, ultrasonic scalpels, and pacemakers and catheters related to examination, diagnosis, and treatment of the heart and blood vessels; X-ray fluoroscopy and CT equipment for tumor and embolism treatment, and endoscopes for cancer treatment; and diagnostic imaging equipment, such as MRI and CT to ventilators, and intraoperative monitors, as well as operating room equipment, including shadowless lights. This segment also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemical, immunological, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The Specialty Product Delivery (SPD) Business segment provides inventory management, medical material masters and data analysis, and purchase management services. The Nursing Care Products Business segment engages in the sale and rental of nursing care equipment; the sale of welfare equipment, such as portable toilets and bathing chairs; and home renovation works, as well as provides nursing care services. The company was formerly known as Kawanishi Holdings, Inc. and changed its name to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021. OLBA HEALTHCARE HOLDINGS, Inc. was founded in 1921 and is headquartered in Okayama, Japan.